Mark Niederschulte

Mark Niederschulte serves as CEO at Jupeng Bio, Inc.. Jupeng Bio, Inc. operates in the biotechnology sector with approximately 30.0 employees. The company is headquartered in League City, Texas.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 2 executives at Jupeng Bio, Inc..
• • 6,856 executive contacts are available in Texas.
• • Our database includes 201,469 c suite-level executives.

Outlook Microsoft Office 365 Errorception Keen.io Google Tag Manager Google Analytics Mobile Friendly Ruby On Rails Vimeo Remote

biofuel bioethanol renewable energy sustainable technology gasification fermentation process technology syngas biocatalyst carbon conversion waste-to-fuel industrial-scale technology greenhouse gas reduction environmental sustainability high purity ethanol clean energy waste management energy efficiency carbon footprint cellulosic ethanol biochemical process renewable power feedstock flexibility renewable fuel automotive fuel bacterial fermentation thermochemical process agricultural waste municipal solid waste biomass energy carbon monoxide food waste recycling low-cost feedstock energy recovery environmentally friendly waste-to-energy biogenic waste energy independence renewable raw materials clean transportation lower carbon emissions job creation community energy local energy production environmental impact clean energy & technology environmental services renewables & environment

BW

Bruce Walker Chief Operating Officer and Chief Technology Officer at Jupeng Bio, Inc.

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Mark Niederschulte, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Mark Niederschulte's Position in the MessageCEO Database

• •Mark Niederschulte is 1 of 2 verified executive contacts we track at Jupeng Bio, Inc..
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •6,405 verified executive contacts in Texas are in the database.
• •9 verified contacts work at biotechnology companies in the 30.0 employee range (same size as Jupeng Bio, Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Mark Niederschulte directly?

Mark Niederschulte's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Jupeng Bio, Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Mark Niederschulte work for?

Mark Niederschulte is CEO at Jupeng Bio, Inc., a company in the biotechnology sector with 30.0 employees. The company is based in League City, Texas.

Can I pitch or sell to Mark Niederschulte?

As CEO at Jupeng Bio, Inc., Mark Niederschulte is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Mark Niederschulte directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Mark Niederschulte in?

Mark Niederschulte works in the biotechnology industry as CEO at Jupeng Bio, Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Mark Niederschulte's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mark Niederschulte's profile is kept up-to-date with the latest available information.

Last updated: June 26, 2026